ENSG
The Ensign Group, Inc.
ENSG's fundamentals are strong: revenue grew 17% and free cash flow grew 45%. At 28x earnings, it's trading in line with its usual 26x. Analysts expect earnings growth.
ENSG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
ENSG's revenue, profitability, cash flow and balance sheet are all currently healthy.
ENSG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 22x | $187 | — |
| Cheap | 23x | $153 | -18% |
| Fair | 25x | $171 | -8.2% |
| Current | 28x | $187 | — |
| Expensive | 32x | $216 | +16% |
Historical ranges are pointers, not guarantees.
ENSG's PE is in its expensive range at 28x. If earnings grow as analysts expect, today's price would be 22x next year's earnings, in its cheap range.
ENSG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ENSG, with profitability holding steady.
ENSG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.60 | +28% |
| Q3 2026 | $6.72 | +20% |
| Q2 2026 | $6.38 | +16% |
| Q1 2026 | $6.14 | +16% |
| Q4 2025 | $5.84 | +14% |
| Q3 2025 | $5.60 | +36% |
| Q2 2025 | $5.52 | +42% |
| Q1 2025 | $5.30 | +40% |
| Q4 2024 | $5.12 | +40% |
ENSG's earnings per share have climbed steadily: $6.72 over the past year, up 20% from the year before, and higher year over year for eight quarters in a row.
ENSG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +14% |
| Q2 2026 | $1.4B | +17% |
| Q1 2026 | $1.4B | +18% |
| Q4 2025 | $1.4B | +20% |
| Q3 2025 | $1.3B | +20% |
| Q2 2025 | $1.2B | +18% |
| Q1 2025 | $1.2B | +16% |
| Q4 2024 | $1.1B | +15% |
ENSG's revenue has grown year over year every quarter since late 2020: $1.5B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.3% | +1.9 points |
| Q2 2026 | 8.5% | 0 points |
| Q1 2026 | 9% | +0.3 points |
| Q4 2025 | 9.1% | +0.2 points |
| Q3 2025 | 7.4% | -0.8 points |
| Q2 2025 | 8.5% | +0.2 points |
| Q1 2025 | 8.6% | +0.5 points |
| Q4 2024 | 8.9% | +6.6 points |
ENSG's operating margin was 9.3% last quarter, up 1.9 points from the same quarter a year ago.
ENSG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $240.2M | +57% |
| Q2 2026 | $172M | +10% |
| Q1 2026 | $100.2M | +39% |
| Q4 2025 | $183.3M | +82% |
| Q3 2025 | $153M | +14% |
| Q2 2025 | $155.7M | +102% |
| Q1 2025 | $72.2M | +105% |
| Q4 2024 | $100.5M | +18% |
ENSG's free cash flow has been positive every quarter for seven years: $696M over the past year, up 45% from the year before.
ENSG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -180K shares |
| 1 year | +0.6% | +347K shares |
| 3 years | +3.4% | +2M shares |
| 5 years | +4.1% | +2.3M shares |
| Available history | +5.9% | +3.3M shares |
ENSG has 59M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $7.4M |
| Q2 2026 | $40M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $9.2M |
| Q1 2025 | $10.8M |
| Q4 2023 | — |
ENSG spent $47M buying back its own shares over the past year.
ENSG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
ENSG has more cash than debt.
ENSG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.6 | Neutral |
| Stochastic | 70.3 | Neutral |
ENSG's weekly RSI is 60 (neutral) and its Stochastic is 70 (neutral).
ENSG PE vs Healthcare Sector
| Metric | ENSG | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 26x | 7.4% above |
| PE % | 66 | 29 | 37 pts above |
ENSG is trading at 28x earnings, in line with the Healthcare sector's median of 26x.
ENSG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $177.5 | 5.1% above |
| 20 week MA | $175.8 | 6.1% above |
| 50 week MA | $181.0 | 3.1% above |
| 100 week MA | $165.7 | 13% above |
| 200 week MA | $139.9 | 33% above |
ENSG is in an uptrend: it's above all five of its weekly moving averages, and 33% above its 200-week average.
ENSG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.7 | $72.8 | +63% |
| 2021 | $72.8 | $81.8 | +12% |
| 2022 | $81.8 | $95.0 | +16% |
| 2023 | $95.0 | $112.2 | +18% |
| 2024 | $112.2 | $134.0 | +19% |
| 2025 | $134.0 | $176.4 | +32% |
| 2026 YTD | $176.4 | $186.5 | +5.7% |
ENSG has finished every year since 2020 higher, and it's up 5.7% so far in 2026.